Comments
Tata Medical and Diagnostics, the healthcare unit of the Tata Group, launched its Covid-19 test kit on Monday, which will be made available at laboratories and hospitals from December, its CEO, Girish Krishnamurthy, told Reuters on Monday.
The government-approved test, which can provide the final result within 90 minutes, will be manufactured at Tata’s plant in Chennai, which has the capacity to produce 1 million test kits a month, Krishnamurthy said in an interview.
Tata CRISPR Covid-19 test gets regulatory approval for commercial use
The launch comes as India’s Covid-19 cases rise by 45,903 to 8.55 million with deaths rising by 490 to 1,26,611, government data showed on Monday.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.